共 50 条
- [21] THE MB49 MURINE UROTHELIAL CARCINOMA: A MOLECULAR AND PHENOTYPIC COMPARISON TO HUMAN CELL LINES AS A MODEL FOR STUDYING THE DIRECT TUMOR RESPONSE TO BCG [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 412 - 412
- [22] Rare, but important complication after BCG Instillation Therapy after Urothelial Carcinoma [J]. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2013, 185 (12): : 1199 - 1200
- [23] BCG induced gene transactivation inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic agents [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 206 - 206
- [25] Re: Impact of Upper Tract Urothelial Carcinoma on Response to BCG in Patients With Nonemuscle-invasive Bladder Cancer [J]. JOURNAL OF UROLOGY, 2022, 208 (06): : 1349 - 1349
- [27] PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders [J]. Virchows Archiv, 2020, 477 : 269 - 277
- [28] BCG resistant bladder urothelial carcinoma underexpresses ligands for natural cytotoxicity receptors of natural killer cells. [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 518 - 518
- [29] BCG induces necrotic cell death in urothelial carcinoma cells associated with the release of the chemokine HMGB1 [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 370 - 370